ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08535
0,00%
Bitcoin
68.703,85
0,25%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Adhera Therapeutics Inc (PK) (ATRX)

  7. Adhera Therapeutics Inc (PK) (ATRX) News

ATRX

Adhera Therapeutics (PK) (ATRX)

Adhera Therapeutics Inc (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:ATRX
DatumZeitQuelleÜberschriftSymbolFirma
30/01/202422h00Edgar (US Regulatory)Form SEC STAFF ACTION - SEC Staff Action: ORDERUSOTC:ATRXAdhera Therapeutics Inc (PK)
18/01/202422h25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
16/01/202422h01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
29/11/202322h01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
20/11/202322h51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ATRXAdhera Therapeutics Inc (PK)
15/11/202322h35Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ATRXAdhera Therapeutics Inc (PK)
12/10/202322h58Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
21/08/202321h32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ATRXAdhera Therapeutics Inc (PK)
15/08/202322h05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ATRXAdhera Therapeutics Inc (PK)
29/06/202322h54Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (PK)
22/05/202321h14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
05/05/202322h03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
04/05/202322h07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
31/03/202321h17Edgar (US Regulatory)Annual Report (10-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
08/03/202322h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
23/02/202323h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
26/01/202322h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
02/12/202223h08Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ATRXAdhera Therapeutics Inc (PK)
22/11/202219h25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
14/11/202221h24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
09/11/202223h19Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
09/09/202222h22Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
25/08/202222h07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (PK)
18/08/202218h48Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ATRXAdhera Therapeutics Inc (PK)
15/08/202221h48Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
06/07/202222h02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ATRXAdhera Therapeutics Inc (PK)
17/06/202222h02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ATRXAdhera Therapeutics Inc (PK)
16/05/202222h16Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (PK)
29/04/202222h58Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:ATRXAdhera Therapeutics Inc (PK)
21/04/202222h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ATRXAdhera Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:ATRX

Kürzlich von Ihnen besucht

BIT
P1ZMZ0
NLBNPIT1ZMZ0 20240621 21
EU
US37
Lyxor Asset Management L...
BIT
P225I1
NLBNPIT225I1 20240920 5.5
COIN
OVOUSD
ICOVO
BIT
P1XPC7
NLBNPIT1XPC7 20240621 0.96
BIT
P1VGS6
NLBNPIT1VGS6 20991231 25...
NASDAQ
XHLIX
Hamilton Lane Private As...
TG
GRP
Greencoat Renewables
BIT
P206H3
NLBNPIT206H3 20241220 32
BIT
P201K8
NLBNPIT201K8 20351221 1....
NASDAQ
TCBC
TC Bancshares
BIT
P1UBY7
NLBNPIT1UBY7 20351221 16...
USOTC
AITA
Wunong Asia Pacific (GM)
BIT
P21LJ7
NLBNPIT21LJ7 20241218 15...
NASDAQ
USCT
Roth CH Acquisition
BIT
P1Y6Z7
NLBNPIT1Y6Z7 20240920 15
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten